Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential BV-AVD Therapy in Richter Transformation: Insights Into the Management of Elderly Patients.

Hematological oncology·2026
Same author

B-cell and plasma cell proliferations associated with T follicular helper cell lymphomas: clinical-pathological and genetic features.

Virchows Archiv : an international journal of pathology·2026
Same author

Joint Assessment of CD38, CD138, and Immunoglobulin Light Chains Supports the Differential Diagnosis Between Classical Hodgkin Lymphoma and Plasmablastic Lymphoma.

International journal of laboratory hematology·2026
Same author

RAG1/2 expression in IGH-switched follicular lymphoma associated with transformation to high-grade B-cell lymphoma.

Leukemia·2026
Same author

Liposomal Encapsulation Reduces the Cytotoxic Effects of Gramicidin S in Monolayer and Spheroid Fibroblast Cultures.

Antibiotics (Basel, Switzerland)·2026
Same author

Flow cytometry, cytology and histology in the diagnosis of ocular hematologic neoplasms: a 15-year monocentric experience with a focus on ocular lymphomas.

Clinical chemistry and laboratory medicine·2025

Related Experiment Video

Updated: Jun 10, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis.

Matteo Fassan1, Marco Pizzi, Giorgio Battaglia

  • 1Department of Medical Diagnostic Sciences, University of Padova, Padova, Italy.

Journal of Clinical Pathology
|August 13, 2010
PubMed
Summary
This summary is machine-generated.

Programmed cell death 4 (PDCD4) expression significantly decreases during Barrett's carcinogenesis, indicating its role in disease progression. Upregulated miR-21 confirms its function as a PDCD4 regulator in Barrett's oesophagus.

More Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

Related Experiment Videos

Last Updated: Jun 10, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

Area of Science:

  • Gastroenterology and Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Barrett's oesophagus (BE) is a precursor to oesophageal adenocarcinoma.
  • Understanding the molecular mechanisms driving BE progression is crucial for early detection and treatment.

Purpose of the Study:

  • To investigate the role of the programmed cell death 4 (PDCD4) tumor suppressor gene in Barrett's carcinogenesis.
  • To assess the relationship between PDCD4 expression and the stages of Barrett's oesophagus progression.

Main Methods:

  • PDCD4 expression was analyzed using immunohistochemistry in 88 Barrett's mucosa biopsy samples.
  • Samples included non-intestinal metaplasia, intestinal metaplasia, low-grade and high-grade intraepithelial neoplasia, and adenocarcinoma.
  • miR-21 expression, a PDCD4 regulator, was quantified using real-time PCR in select samples.

Main Results:

  • PDCD4 expression significantly decreased with advancing stages of Barrett's carcinogenesis (p<0.001).
  • Strong nuclear PDCD4 staining was observed in normal and metaplastic tissues, decreasing in dysplastic and neoplastic lesions.
  • miR-21 levels were upregulated in high-grade neoplasia and adenocarcinoma, correlating with PDCD4 downregulation.

Conclusions:

  • PDCD4 downregulation plays a significant role in the progression from Barrett's mucosa to adenocarcinoma.
  • miR-21 acts as a negative regulator of PDCD4 in vivo.
  • PDCD4 may serve as a potential prognostic marker for patients with Barrett's oesophagus.